General Western Blot Reagents
Abcam C x 546, AMPA receptor potentiator, 50MG
MW 247.29 Da, Purity >99%. AMPA receptor potentiator. Selectively binds to the agonist bound non-desensitized receptor. Destabilizes desensitized receptor conformation with greater potency than CX516. Enhances cognitive function in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Methyl heneicosanoate, long chain fatty acid methyl ester, 100MG
MW 340.6 Da, Purity >99%. Very long chain fatty acid methyl ester See similar products
The product is subject to the following: Abcam Restricted Use Statement
Abcam 1,2-Dimyristoyl-sn-glycero-3-phosphorylglycerol sodium salt (DMPG), Phosphatidylglycerol, 100MG
MW 688.8 Da, Purity >98%. Phosphatidylglycerol. For use in lipid bilayer studies and biological systems. See similar compounds
The product is subject to the following: Abcam Restricted Use Statement
Abcam MRS 2179, P2Y1 antagonist, 10MG
MW 460.27 Da, Purity >98%. Potent, selective, competitive P2Y1 antagonist (Ki = 100 nM). Inhibits ATP induced glutamate release *in vitro* and inhibits ADP ability to evoke platelet shape change and aggregation.
The product is subject to the following: Abcam Restricted Use Statement
Abcam KDM4JMJD2 Activity Quantification Assay Kit (Fluorometric)
KDM4JMJD2 Activity Quantification Assay Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Pyocyanin, Catalase inhibitor, 25MG
MW 210.23 Da, Purity >98%. Catalase inhibitor. Aryl hydrocarbon receptor activator (Ki = 5.4 μM). Reduces gene expression of catalase. Promotes extracellular DNA release. Generates ROS. Induces apoptosis in neutrophils in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Tamo x ifen citrate, Estrogen receptor antagonist and partial agonist, 100MG
MW 563.65 g/mol, Purity >99%. Competitive estrogen receptor antagonist and partial agonist. Inhibits estrogen dependent gene transcription and tumor growth. Additionally decreases cardiac infarction and inhibits Kir2.1, Kir2.2 and Kir2.3 potassium channels (IC₅₀ values are 0.93, 0.87 and 0.31 μM, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam tBuBHQ (BHQ), Sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, 500MG
MW 222.32 Da, Purity >99%. Sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Medro x yprogesterone 17-acetate, Progesterone receptor agonist, 500MG
MW 386.5 Da, Purity >99%. Angiostatic steroid. Inhibit vascularization, collagenolysis, tumor growth and plasmin generation. Synthetic variant of progesterone, and a potent progesterone receptor agonist. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Fluo 8 Calcium Assay Kit Medium Removal
Fluo 8 Calcium Assay Kit Medium Removal
The product is subject to the following: Abcam Restricted Use Statement
Abcam Aldehyde Assay Kit (Colorimetric)
Aldehyde Assay Kit (Colorimetric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam MMP Activity Assay Kit (Fluorometric Red)
MMP Activity Assay Kit (Fluorometric Red)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Fluo 8 Calcium Assay Kit Medium Removal
Fluo 8 Calcium Assay Kit Medium Removal
The product is subject to the following: Abcam Restricted Use Statement